| 9840519 |
Macrocyclic compounds as TRK kinase inhibitors |
Steven W. Andrews, Kevin Ronald Condroski, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +2 more |
2017-12-12 |
| 9809590 |
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors |
Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska +7 more |
2017-11-07 |
| 9750744 |
Macrocyclic compounds as Trk kinase inhibitors |
Steven W. Andrews, Kevin Ronald Condroski, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +2 more |
2017-09-05 |
| 9732119 |
Immunomodulators |
Li-Qiang Sun, Eric Mull, Eric P. Gillis, Paul Michael Scola |
2017-08-15 |
| 9718822 |
Macrocyclic compounds as Trk kinase inhibitors |
Steven W. Andrews, Kevin Ronald Condroski, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +2 more |
2017-08-01 |
| 9693989 |
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
Joseph P. Lyssikatos, Julie Marie Hicks, Fredrik P. Marmsater |
2017-07-04 |
| 9688672 |
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH |
Thomas Raymond Caferro, Zhuoliang Chen, Young Shin Cho, Abran Q. Costales, Julian Levell +7 more |
2017-06-27 |
| 9676791 |
Quinazoline analogs as receptor tyrosine kinase inhibitors |
Eli M. Wallace, George T. Topalov, Joseph P. Lyssikatos, Alexandre Joseph Buckmelter |
2017-06-13 |
| 9643999 |
Hepatitis C virus inhibitors |
Li-Qiang Sun, Kishore V. Renduchintala, Kandhasamy Sarkunam, Pulicharla Nagalakshmi, Eric P. Gillis +1 more |
2017-05-09 |
| 9624245 |
Macrocyclic compounds as HCV entry inhibitors |
Tao Wang, Zhongxing Zhang, Zhiwei Yin, Li-Qiang Sun, Eric Mull +1 more |
2017-04-18 |
| 9598433 |
Hepatitis C virus inhibitors |
Li-Qiang Sun, Eric P. Gillis, Eric Mull, Michael S. Bowsher, Paul Michael Scola |
2017-03-21 |